BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2021 11:15:33 AM | Browse: 373 | Download: 406
 |
Received |
|
2021-04-23 00:57 |
|
Peer-Review Started |
|
2021-04-23 00:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-23 02:16 |
|
Revised |
|
2021-07-09 04:25 |
|
Second Decision |
|
2021-10-27 09:17 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-10-27 21:36 |
|
Articles in Press |
|
2021-10-27 21:36 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-11-16 14:18 |
|
Publish the Manuscript Online |
|
2021-11-19 11:15 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mina S Makary, Stuart Ramsell, Eric Miller, Eliza W Beal and Joshua D Dowell |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mina S Makary, MD, Assistant Professor, Attending Doctor, Director, Department of Radiology, The Ohio State University Wexner Medical Center, 395 W. 12th Ave, 4th Floor, Columbus, OH 43210, United States. mina.makary@osumc.edu |
| Key Words |
Hepatocellular carcinoma; Bland embolization; Chemoembolization; Radioembolization; Transarterial embolization; Thermal ablation; Locoregional therapy |
| Core Tip |
This article reviews prognostic factors and outcomes of current locoregional therapies for hepatocellular carcinoma, as well as future directions and promising new techniques. Therapies including transarterial bland embolization, chemoembolization, and radioembolization, as well as percutaneous ablation are reviewed. Prognostic considerations vary by indication but generally follow baseline disease staging and tumor quantification. Outcomes data reveal survival benefits in appropriately selected patients. New advances in precision medicine, combination therapy, and immunotherapy are being investigated. |
| Publish Date |
2021-11-19 11:15 |
| Citation |
Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World J Gastroenterol 2021; 27(43): 7462-7479 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i43/7462.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i43.7462 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
